Authors: DeFeo-Jones, D Garsky, VM Wong, BK Feng, DM Bolyar, T Haskell, K Kiefer, DM Leander, K McAvoy, E Lumma, P Wai, J Senderak, ET Motzel, SL Keenan, K Van Zwieten, M Lin, JH Freidinger, R Huff, J Oliff, A Jones, RE

Citation: D. Defeo-jones et al., A peptide-doxorubicin 'prodrug' activated by prostate-specific antigen selectively kills prostate tumor cells positive for prostate-specific antigen in vivo, NAT MED, 6(11), 2000, pp. 1248-1252

Authors: Williams, TM Bergman, JM Brashear, K Breslin, MJ Dinsmore, CJ Hutchinson, JH MacTough, SC Stump, CA Wei, DD Zartman, CB Bogusky, MJ Culberson, JC Buser-Doepner, C Davide, J Greenberg, IB Hamilton, KA Koblan, KS Kohl, NE Liu, DM Lobell, RB Mosser, SD O'Neill, TJ Rands, E Schaber, MD Wilson, F Senderak, E Motzel, SL Gibbs, JB Graham, SL Heimbrook, DC Hartman, GD Oliff, AI Huff, JR

Citation: Tm. Williams et al., N-arylpiperazinone inhibitors of farnesyltransferase: Discovery and biological activity, J MED CHEM, 42(19), 1999, pp. 3779-3784